COVID-19 Impact on Global Pharmaceutical Excipients Market: The COVID-19 pandemic had a significant impact on the pharma industry. Lockdowns imposed in the wake of the outbreak disrupted the supply of raw materials from manufacturing hubs such as India and China. This slowed drug development and …
The pharmaceutical excipients market is projected to reach USD 9.7 billion by 2025 from USD 6.9 billion in 2019, at a CAGR of 5.8%. Factors such as the growing pharmaceuticals industry coupled with advancements in functional excipients, rising adoption of orphan drugs, and increasing uptake …
Expected Revenue Growth: The global pharmaceutical excipients market is projected to reach USD 9.7 billion by 2025 from USD 6.9 billion in 2019, at a CAGR of 5.8% during the forecast period. Major Growth Boosters: The overall growth of the pharmaceutical excipients market is largely …
Global Overview of This Study: The study involved 4 major activities in estimating the current market size for pharmaceutical excipients market. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to …
The study involved 4 major activities in estimating the current market size for Global Pharmaceutical Excipients Market. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and …
The pharmaceutical excipients market is consolidated, with the top four players accounting for nearly 30%-35% of the market in 2015. The majority of the leading players in the market are based in developed countries across North America and Europe. Ashland, Inc. (U.S.) is the leading …
Pharmaceuticals play a vital role in the well-being of human beings in the form of medications and drugs, with one of the category being excipients. Pharmaceutical excipients are natural or synthetic substances that help in increasing the stability of drugs which are formulated with active …